Home/Filings/4/0001415889-22-007540
4//SEC Filing

Kirby John J. 4

Accession 0001415889-22-007540

CIK 0000861838other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 5:27 PM ET

Size

5.6 KB

Accession

0001415889-22-007540

Insider Transaction Report

Form 4
Period: 2022-07-06
Kirby John J.
V.P. of Finance, PFO & PAO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-06+66,50066,500 total
    Exercise: $0.43Exp: 2032-07-06Common Stock (66,500 underlying)
Footnotes (1)
  • [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on July 6, 2026, with 25% vesting on July 6, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001556327

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:27 PM ET
Size
5.6 KB